Trauma pp 273-302 | Cite as

Anesthetic Problems in Trauma Management

  • John R. Gordon


The discussion of anesthetic problems in trauma management is restricted to the role of recently developed drugs in general anesthesia. It deals with two new inhalation anesthetics enflurane and isoflurane; with the intravenous agents ketamine hydrochloride, a dissociative anesthetic, and droperidol-fentanyl as employed in neuroleptanalgesia; and with one new, and one old, neuromuscular blocking drug. In addition the perennial problem of the trauma victim with a full stomach who requires general anesthesia is presented in detail.


Cardiac Arrest Endotracheal Intubation Serum Potassium Full Stomach Cricoid Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Alexander, R. S.: Tonic and reflex functions of medullary sympathetic cardiovascular centers. J. Neurophysiol. 9: 205–217, 1946.Google Scholar
  2. 2.
    Allan, C. M., Cullen, W. G., and Gillies, D. M. M.: Ventricular fibrillation in a burned boy. Canad, Med. Ass. J. 85: 432–434, 1961.Google Scholar
  3. 3.
    Axelsson, J., and Thesleff, S.: A study on supersensitivity in denervated mammalian skeletal muscle. J. Physiol. 145: 48P–49P, 1959.Google Scholar
  4. 4.
    Axelsson, J., and Thesleff, S.: A study on supersensitivity in denervated mammalian skeletal muscle. J. Physiol. 147:178–193, 1959.Google Scholar
  5. 5.
    Baird, W. L. M., and Reid, A. M.: The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. Brit. J. Anaesth. 39: 775–780, 1967.Google Scholar
  6. 6.
    Balfour, G. W.: New cause of death under chloroform, Edinburgh Med. J. 8: 194–195, 1862.Google Scholar
  7. 7.
    Bannister, W. K., Sattilaro, A. J., and Otis, R. D.: Therapeutic aspects of aspiration pneumonitis in experimental animals. Anesthesiology 22: 440–443, 1961.Google Scholar
  8. 8.
    Baraka, A., Harrison, T., and Kachachi, T.: Catecholamine levels after ketamine anesthesia in man. Anesth. Analg. 52: 198–200, 1973.Google Scholar
  9. 9.
    Bart, A. J., Homi, J., and Linde, H. W.: Changes in power spectra of electroencephalograms during anesthesia with fluroxene, methoxyflurane and ethrane. Anesth. Analg. 50: 53p63, 1971.Google Scholar
  10. 10.
    Belin, R. P., and Karleen, C. I.: Cardiac arrest in the burned patient following succinylcholine administration. Anesthesiology 27: 516–518, 1966.Google Scholar
  11. 11.
    Bennett, E. J., Daughety, M. J., Bowyer, D. E., and Stephen, C. R.: Pancuronium bromide: experiences in 100 pediatric patients. Anesth. Analg. 50: 798–807, 1971.Google Scholar
  12. 12.
    Bennike, K. A., and Jarnum, S.: Myoglobinuria with acute renal failure possibly induced by suxamethonium, a case report. Brit. J. Anaesth. 36: 730–736, 1964.Google Scholar
  13. 13.
    Birch, A. A., Mitchell, G. D., and Cameron, J. L.: Aspiration pneumonia: pulmonary arteriography after experimental aspiration. J. Surg. Res. 12: 48–52, 1972.Google Scholar
  14. 14.
    Booth, D. J., Zuidema, G. D., Cameron, J. L.: Aspiration pneumonia: pulmonary arteriography after experimental aspiration. J. Surg. Res. 12: 48–52, 1972.Google Scholar
  15. 15.
    Botty, C., Brown, B., Stanley, V., and Stephen, C. R.: Clinical experiences with compound 347, a halogenated anesthetic agent. Anesth. Analg. 47: 499–505, 1968.Google Scholar
  16. 16.
    Brandus, V., Joffe, S., Rubin, J. M.: Histamine-like reaction to tubocurarine. Brit. J. Anaesth. 45: 108–110, 1973.Google Scholar
  17. 17.
    Briddon, C. K.: Death during anaesthesia resulting from the entrance of food into the larynx and trachea. Ann. Surg. 27: 372–373, 1898.Google Scholar
  18. 18.
    Buckett, W. R., and Bonta, I. L.: Pharmacological studies with NA97 (23, 16ß — Dippiperidino — 5a androstane — 3a, 17ß — Diol diacetate dimethobromide). Fed. Proc. 25: 718, 1966.Google Scholar
  19. 19.
    Bullough, J.: Intermittent suxamethonium injections. Brit. Med. J. 5124: 786–787, 1959.Google Scholar
  20. 20.
    Bush, G. H., Graham, H. A. P., Littlewood, A. H. M., and Scott, L. B.: Danger of suxamethonium and endotracheal intubation in anaesthesia for burns. Brit. Med. J. 5312: 1081–1085, 1962.Google Scholar
  21. 21.
    Byles, P. H., Dobkin, A. B., Ferguson, J. H., and Levy, A. A.: Forane (compounc 469): cross-over comparison with enflurane (ethrane), halothane, and methoxyflurane in dogs. Canad. Anaesth. Soc. J. 18: 397–407, 1971.Google Scholar
  22. 22.
    Byles, P. H., Dobkin, A. B., and Jones, D. B.: Forance (compound 469): 3. comparative effects of prolonged anaesthesia on mature beagle dogs and young rhesus monkeys. Canad. Anaesth. Soc. J. 18: 397–407, 1971.Google Scholar
  23. 23.
    Cameron, J. L., Zuidema, G. D.: Aspiration pneumonia: magnitude and frequency of the problem. JAMA 219: 1194–1196, 1972.Google Scholar
  24. 24.
    Chasapakis, G., Kekis, N., Sakkalis, C., and Kolios, D.: Use of ketamine and pancuronium for anesthesia for patients in hemorrhagic shock. Anesth. Analg. 52: 282–287, 1973.Google Scholar
  25. 25.
    Chase, R. E., Holaday, D. A., Fiserova-Bergerova, V., Saidman, L. J., Mack, F. E.: The biotransformation of ethrane in man. Anesthesiology 35: 262–267, 1971.Google Scholar
  26. 26.
    Chen, G.: Sympathomimetic anesthetics. Canad. Anaesth. Soc. J. 20: 180–185, 1973.Google Scholar
  27. 27.
    Claeys, D. W., Lockhart, C. H., and Hinkle, J. E.: The effects of translaryngeal block and innovar on glottic competence. Anesthesiology 38: 485–486, 1973.Google Scholar
  28. 28.
    Coleman, A. J., Downing, J. W., Leary, W. P., Moyes, D. G., Styles, M.: The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man. Anaesthesia 27: 415–422, 1972.Google Scholar
  29. 29.
    Cooperman, L. H.: Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA 213: 1867–1871, 1970.Google Scholar
  30. 30.
    Corssen, G., Domino, E. F.: Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth. Analg. 45: 29–40, 1966.Google Scholar
  31. 31.
    Corssen, G., Domino, E. F., and Sweet, R. G.: Neuroleptanalgesia and anesthesia. Anesth. Analg. 43: 748–763, 1964.Google Scholar
  32. 32.
    Corssen, G., Miyakako, M., and Domino, E. F.: Changing concepts of pain control during surgery: dissociative anesthesia with CI-581. Anesth. Analg. 47: 746–759, 1968.Google Scholar
  33. 33.
    Cromwell, T. H., Stevens, W.D., Eger, E. I., Shakespeare, T. F., Halsey, M. J., Bahlman, S. H., and Fourcade, H. E.: The cardiovascular effects of compound 469 (forane) during spontaneous ventilation and carbon dioxide challenge in man. Anesthesiology 35: 17–25, 1971.Google Scholar
  34. 34.
    Cullen, D. J.: The effect of pretreatment with nondepolarizing muscle relaxants on the neuromuscular blocking action of succinylcholine. Anesthesiology 35: 572–578, 1971.Google Scholar
  35. 35.
    Dick, W., and Droh, R.: Pancuronium bromide: clinical experiences with a new steriod-like relaxant. Anaesthesist 19: 173–176, 1970.Google Scholar
  36. 36.
    Dietzel, W., and Massion, W. H.: The prophylactic effect of innovar in experimental hemorrhagic shock. Anesth. Analg. 48: 968–972, 1969.Google Scholar
  37. 37.
    Dines, D. E., Baker, W. G., and Scantland, W. A.: Aspiration pneumonitis-Mendelson’s syndrome. JAMA 176: 229–231, 1961.Google Scholar
  38. 38.
    Dixon, S. H., Nolan, S. P., Stewart, S., and Morrow, A. G.: Neuroleptanalgesia: effects of innovar on myocardial contractility, total peripheral resistance, and capacitance. Anesth. Analg. 49: 331–335, 1970.Google Scholar
  39. 39.
    Dobkin, A. B., Byles, P. H., Arandia, H. Y., Ghanooni, S., Nishioka, K., and Levy, A. A.: Comparative metabolic responses to halogenated anaesthetics. Acta Anaesth. Scand. 16: 69–75, 1972.Google Scholar
  40. 40.
    Dobkin, A. B., Byles, P. H., Ghanooni, S., and Valbuena, D. A.: Clinical and laboratory evaluation of a new inhalation anesthetic: forance (compound 469) CHF2-O-CH C1 CF3. Canad. Anaesth. Soc. J. 18: 264–271, 1971.Google Scholar
  41. 41.
    Dobkin, A. B., Byles, P. H., and Neville, J. F.: Neuroendocrine and metabolic effects of general anaesthesia during spontaneous breathing, controlled breathing, mild hypoxia and mild hypercarbia. Canad. Anaesth. Soc. J. 13: 130–171, 1966.Google Scholar
  42. 42.
    Dobkin, A. B., Evers, W., Ghanooni, S., Levy, A. A., Thomas, E. T.: Pancuronium bromide: evaluation of its clinical pharmacology. Canad. Anaesth. Soc. J. 18: 512–535, 1971.Google Scholar
  43. 43.
    Dobkin, A. B., Kwang, P., Lee, Y., Byles, Ph. H., Israel, J. S.: Neuroleptanalgesics: a comparison of the cardiovascular, respiratory and metabolic effects of innovar and thiopentone plus methotrimeprazine. Brit. J. Anaesth. 35: 694–705, 1963.Google Scholar
  44. 44.
    Dobkin, A. B., Nishioka, K., Gengaze, D. B., Kim, D. S., Evers, W., Israel, J. S.: Ethrane (compound 347) anesthesia: a clinical and laboratory review of 700 cases. Anesth. Analg. 48: 477–494, 1969.Google Scholar
  45. 45.
    Domino, E. F., Chodoff, P., and Corssen, G.: Pharmocologic effects of CI-581, a new dissociative anesthetic, in man. Clin. Pharmacol. Ther. 6: 279–291, 1965.Google Scholar
  46. 46.
    Doughty, A. G., and Wylie, W. D.: An assessment of gallamine triethiodide. Proc. Roy. Soc. Med. 44: 375–388, 1951.Google Scholar
  47. 47.
    Dowdy, E. G., Kaya, K.: Studies of the mechanism of cardiovascular responses to CI-581. Anesthesiology 29: 931–943, 1968.Google Scholar
  48. 48.
    Dundee, J. W., Bovill, J. G., Clarke, R. S. F., Pandit, S. K.: Problems with ketamine in adults. Anaesthesia 26: 86, 1971.Google Scholar
  49. 49.
    Edwards, G., Morton, H. J. V., Pask, E. A., Wylie, W. D.: Deaths associated with anaesthesia. Anaesthesia 11: 194–220, 1956.Google Scholar
  50. 50.
    Eger, E. I., Dolan, W. M., Stevens, W. C., Miller, R. D., Way, W. L.: Surgical stimulation antagonizes the respiratory depression produced by forane. Anesthesiology 36: 544–549, 1972.Google Scholar
  51. 51.
    Fatal application of chloroform. Lancet 1: 161-162, 1848.Google Scholar
  52. 52.
    Ferrer-Allado, T., Brechner, V. L., Dymond, A., Cozen, H., Crandall, P.: Ketamine-induced electroconvulsive phenomena in the human limbic and thalamic regions. Anesthesiology 38: 333–344, 1973.Google Scholar
  53. 53.
    Finer, B. L., Nylen, B. O.: Double cardiac arrest with survival. Brit. Med. J. 5122: 624–625, 1959.Google Scholar
  54. 54.
    Finer, B. L., Nylen, B. O.: Cardiac arrest in the treatment of burns, and report on hypnosis as a substitute for anesthesia. Plast. Reconstr. Surg. 27: 49–55, 1961.Google Scholar
  55. 55.
    Fleming, W. B., Hueston, J. T., Stubbe, J. L., Villiers, J. D.: Two episodes of cardiac arrest in one week. Brit. Med. J. 5167: 157–160, 1960.Google Scholar
  56. 56.
    Foldes, F. E., McNall, P. G., Borrego-Hinojosa, J. M.: Succinylcholine: a new approach to muscular relaxation in anesthesiology. New Eng. J. Med. 274: 596–600, 1952.Google Scholar
  57. 57.
    Forrest, T.: A report on two cases of cardiac arrest. Brit. J. Anaesth. 31: 277–279, 1959.Google Scholar
  58. 58.
    Fourcade, H. E., Stevens, W. C., Larson, C. P., Cromwell, T. H., Bahlman, S. H., Hickey, R. F., Halsey, M. J., Eger, E. I.: The ventilatory effects of forane, a new inhaled anesthetic. Anesthesiology 35: 26–31, 1971.Google Scholar
  59. 59.
    Gardner, A. E., Olson, B. E., Lichtiger, M.: Cerebrospinalfluid pressure during dissociative anesthesia with ketamine. Anesthesiology 35: 226–228, 1971.Google Scholar
  60. 60.
    Guiffrida, J. G., Bizzarri, D.: Intubation of the esophagus. Amer. J. Surg. 93: 329–334, 1957.Google Scholar
  61. 61.
    Greene, M. J.: Some aspects of the pharmacology of droperidol. Brit. J. Anaesth. 44: 1272–1276, 1972.Google Scholar
  62. 62.
    Halsey, M. J., Sawyer, D. C., Eger, E. I., Bahlman, S. H., Impelman, D. M. K.: Hepatic metabolism of halothane, methoxyflurane, cyclopropane, ethrane and forane in miniature swine. Anesthesiology 35: 43–47, 1971.Google Scholar
  63. 63.
    Holderness, M. C., Chase, P. E., Dripps, R. D.: A narcotic analgesic and a butyrophenone with nitrous oxide for general anesthesia. Anesthesiology 24: 336–340, 1963.Google Scholar
  64. 64.
    Inkster, J. S.: The induction of anaesthesia in patients likely to vomit with special reference to intestinal obstruction. Brit. J. Anaesth. 35: 160–167, 1963.Google Scholar
  65. 65.
    Innes, R. K. R., Stromme, J. H.: Rise in serum creatine phosphokinase associated with agents used in anaesthesia. Brit. J. Anaesth. 45: 185–190, 1973.Google Scholar
  66. 66.
    Janssen, P. A. J., Neimegeers, C. J. E., Shellekens, K. H. L., Verbruggen, F. J. and Van Nueten, J. M.: The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to haloperidol. Arzneimittelforschung 13: 205–211, 1963.Google Scholar
  67. 67.
    Joas, T. A., Stevens, W. C.: Comparison of the arrhythmic doses of epinephrine during forane, halothane and fluroxene anesthesia in dogs. Anesthesiology 35: 48–53, 1971.Google Scholar
  68. 68.
    Katz, R. L.: Pancuronium. 22nd Annual Refresher Course Lectures. A. A. A., Atlanta, 1971, p. 220A, 1-7.Google Scholar
  69. 69.
    Kelman, G. R., Kennedy, B. R.: Cardiovascular effects of pancuronium in man. Brit. J. Anaesth. 43: 335–338, 1971.Google Scholar
  70. 70.
    Klupp, H., Kraupp, O.: The liberation of potassium from muscles under the influence of muscle relaxants. Arch. Int. Pharmacodyn. 98: 340–354, 1954.Google Scholar
  71. 71.
    Laborit, H., Huguenard, P.: Pratique de l’hibernotherapie en chirurgie et en medicine. Paris, Masson, 1954.Google Scholar
  72. 72.
    Larson, C. P., Eger, E. I., Muallem, M., Buechel, D. R., Munson, E. S., Eisele, J. H.: The effects of diethyl ether and methoxyflurane on ventilation: 11. a comparative study in man. Anesthesiology 30: 174–184, 1969.Google Scholar
  73. 73.
    Leigh, M. D., McCoy, D. D., Belton, M. K., Lewis, G. B.: Bradycardia following intravenous administration of succinylcholine chloride to infants and children. Anesthesiology 18: 698–702, 1957.Google Scholar
  74. 74.
    List, W. F.: Serum potassium changes during induction of anaesthesia. Brit. J. Anaesth. 39: 480–484, 1967.Google Scholar
  75. 75.
    Lowenstein, E.: Succinylcholine adminis-ration in the burned patient. Anesthesiology 27: 494–496, 1966.Google Scholar
  76. 76.
    Macintosh, R. R.: A cuffed stomach tube. Brit. Med. J. 2: 545, 1951.Google Scholar
  77. 77.
    Marshall, V. M., Gordon, R. A.: Vomiting, regurgitation and aspiration in anaesthesia I. Canad. Anaesth. Soc. J. 5: 274–281, 1958.Google Scholar
  78. 78.
    Marshall, V. M., Gordon, R. A.: Vomiting, regurgitation and aspiration in anaesthesia II. Canad. Anaesth. Soc. J. 5: 438–447, 1958.Google Scholar
  79. 79.
    Masters, F. W., Hansen, J. M., Robinson, D. W.: Anesthetic complications in plastic surgery. Plast. Reconstr. Surg. 24: 472–480, 1959.Google Scholar
  80. 80.
    McCaughey, T. J.: Hazards of anaesthesia for the burned child. Canad. Anaesth. Soc. J. 9: 220–233, 1962.Google Scholar
  81. 81.
    McCaughey, T. J., Lowenstein, E.: Use of succinylcholine in burned patients (correspondence). Anesthesiology 28: 234–235, 1967.Google Scholar
  82. 82.
    McDowall, S. A., Clarke, R. S. J.: A clinical comparison of pancuronium with d-tubocurarine. Anaesthesia 24: 581–590, 1969.Google Scholar
  83. 83.
    Mendelson, C. L.: Aspiration of stomach contents into lungs during obstetric anesthesia. Amer. J. Obstet. Gynec. 52: 191–205, 1946.Google Scholar
  84. 84.
    Miller, R. D., Way, W. L.: Inhibition of succinylcholineinduced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine. Anesthesiology 34: 567–571, 1971.Google Scholar
  85. 85.
    Miller, R. D., Way, W. L.: The interaction between succinylcholine and sub-paralyzing doses of d-tubocurarine and gallamine in man. Anesthesiology 35: 567–571, 1971.Google Scholar
  86. 86.
    Moncrief, J. A.: Complications of burns. Ann. Surg. 147: 443–475, 1958.Google Scholar
  87. 87.
    Moran, J. E., Rusy, B. F., Vongvisces, P., Lattanand, S.: Effects of halothane-oxygen and innovar-nitrous oxideosygen on the maximum acceleration of left ventricular ejection and the tension-time index in dogs. Anesth. Analg. 51: 350–354, 1972.Google Scholar
  88. 88.
    Mori, K., Kawamata, M., Mitani, H., Yamazaki, Y., Fuzita, M.: Aneurophysiologic study of ketamime anesthesia in the cat. Anesthesiology 35: 373–383, 1971.Google Scholar
  89. 89.
    Morton, H. J. V., Wylie, W. D.: Anaesthetic deaths due to regurgitation or vomiting. Anaesthesia 6: 190–201, 1951.Google Scholar
  90. 90.
    Neigh, J. L., Garman, J. K., Harp, J. R.: The electroencephalographic pattern during anesthesia with ethrane: effects of depty of anesthesia, PaCO2, and nitrous ox ide, Anesthesiology 35: 482–487, 1971.Google Scholar
  91. 91.
    Nettles, D. C., Herrin, T. J., Mullen, J. G.: Ketamine induction in poor-risk patients. Anesth. Analg. 52: 59–64, 1973.Google Scholar
  92. 92.
    Nightingale, D. A., Bush, G. H.: A clinical comparison between tubocurarine and pancuronium in children. Brit. J. Anaesth. 45: 63–70, 1973.Google Scholar
  93. 93.
    Nilsson, E.: Origin and rationale of neurolept-analgesia. Anesthesiology 24: 267–268, 1963.Google Scholar
  94. 94.
    Nilsson, E., Janssen, P.: Neurolept-analgesia, an alternative to general anesthesia. Acta Anaesth. Scand. 5: 73–84, 1961.Google Scholar
  95. 95.
    Oyama, T., Matsumoto, F., Kudo, T.: Effects of ketamine on adrenocortical function in man. Anesth. Analg. 49: 697–700, 1970.Google Scholar
  96. 96.
    Paton, W. D. M.: Mode of action of neuromuscular blocking agents. Brit. J. Anaesth. 28: 470–480, 1956.Google Scholar
  97. 97.
    Paton, W. D. M.: The effects of muscle relaxants other than muscular relaxation. Anesthesiology 20: 453–463, 1959.Google Scholar
  98. 98.
    Penrose, B. H.: Aspiration penumonities following ketamine induction for general anesthesia. Anesth. Analg. 51: 41–43, 1972.Google Scholar
  99. 99.
    Puddy, B. R.: Effects of droperidol on the vasoconstriction produced by noradrenaline, histamine, sympathetic nerve stimulation and potassium ions in the isolated rabbit auricular artery. Brit. J. Anaesth. 43: 441–444, 1971.Google Scholar
  100. 100.
    Roth, F., Wuthrich, H.: The clinical importance of hyperkalemia following suxamethonium administration. Brit. J. Anaesth. 41: 311–316, 1969.Google Scholar
  101. 101.
    Ryan, J. F., Kagen, L. J., Hyman, A. I.: Myoglobinemia after single dose of succinylcholine. New Eng. J. Med. 285: 824–887, 1971.Google Scholar
  102. 102.
    Salem, M. R.: Anesthetic management of patients with “a full stomach.” Anesth. Analg. 49: 47–55, 1970.Google Scholar
  103. 103.
    Sawyer, D. C., Eger, E. I., Bahlman, S. H., Cullen, B. F., Impelman, D.: Concentration dependence of hepatic halothane metabolism. Anesthesiology 34: 230–235, 1971.Google Scholar
  104. 104.
    Schaner, P. J., Brown, R. L., Kirksey, T. D., Gunther, R. C., Ritchey, C. R., Gronert, G. A.: Succinylcholine-induced hyperkalemia in burned patients. Anesth. Analg. 48: 764–770, 1969.Google Scholar
  105. 105.
    Sellick, B. A.: Cricoid pressure to control regurgitation of stomach contents during induction of anaesthesia. Lancet 2: 404–405, 1961.Google Scholar
  106. 106.
    Simpson, J. Y.: Remarks on the alleged case of death from the action of chloroform. Lancet 1: 175–176, 1848.Google Scholar
  107. 107.
    Skovsted, P., Price, H. L.: The effect of methoxyflurane on arterial pressure, preganglionic sympathetic activity and barostatic reflexes. Anesthesiology 31: 515–521, 1969.Google Scholar
  108. 108.
    Skovsted, P., Price, H. L.: Central sympathetic excitation caused by diethyl ether. Anesthesiology 32: 202–209, 1970.Google Scholar
  109. 109.
    Skovsted, P., Price, H. L.: Central sympathetic excitation caused by fluroxene. Anesthesiology 32: 210–217, 1970.Google Scholar
  110. 110.
    Skovsted, P., Price, H. L.: The effects of ethrane on arterial pressure, preganglionic sympathetic activity and barostatic reflexes. Anesthesiology 36: 257–262, 1972.Google Scholar
  111. 111.
    Skovsted, P., Price, M. L., Price, H. L.: The effect of halothane on arterial pressure, preganglionic sympathetic activity and barostatic reflexes. Anesthesiology 31: 507–514, 1969.Google Scholar
  112. 112.
    Slogoff, M. D., Allen, G. W., Mendenhall, M. K.: Use of halothane in the management of burns. Clin. Aspects of Anesthesiology (Ayerst) Dec, 1972.Google Scholar
  113. 113.
    Smith, T. N., Corbascio, A. N.: The hemodynamic effects of potassium infusion in dogs. Anesthesiology 26: 633;641, 1965.Google Scholar
  114. 114.
    Snow, R. G., Nunn, J. F.: Induction of anaesthesia in the foot-down position with a full stomach. Brit. J. Anaesth. 31: 493–497, 1959.Google Scholar
  115. 115.
    Stept, W. J., Safar, P.: Rapid induction/intubation for prevention of gastric-content aspiration. Anesth. Analg. 49: 633–635, 1970.Google Scholar
  116. 116.
    Stevens, W. C., Cromwell, T. H., Halsey, M. J., Eger, E. I., Shakespeare, T. F., Bahlman, S. H.: The cardiovascular effects of a new inhalation anesthetic, forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology 35: 8–16, 1971.Google Scholar
  117. 117.
    Stoelting, R. K.: The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 36: 612–615, 1972.Google Scholar
  118. 118.
    Stovner, J., Endresen, R., Bjelke, E.: Suzamethonium hyperkalemia with different induction agents. Acta Anaesth. Scand. 16: 46–50, 1972.Google Scholar
  119. 119.
    Takki, S., Kauste, A., Kjellberg, M.: Prevention of suxamethonium-induced fasciculations by prior dose of d-tubocurarine. Acta Anaesth. Scand. 16: 230–234, 1972.Google Scholar
  120. 120.
    Takki, S., Nikki, P., Jaattela, A., Tammisto, T.: Ketamine and plasma catecholamines. Brit. J. Anaesth. 44: 1318–1322, 1972.Google Scholar
  121. 121.
    Tammisto, T., Airaksinen, M.: Increase of creatine kinase activity in serum as a sign of muscular injury caused by intermittently administered suxamethonium during halothane anaesthesia. Brit. J. Anaesth. 38: 510–515, 1966.Google Scholar
  122. 122.
    Tarhan, S., Moffitt, E. A., Lundborg, R. O., Frye, R. L.: Hemodynamic and blood-gas effects of innovar in patients with acquired heart disease. Anesthesiology 34: 250–255, 1971.Google Scholar
  123. 123.
    Thomas, E. T.: Circulatory collapse following succinylcholine. Anesth. Analg. 48: 333–337, 1969.Google Scholar
  124. 124.
    Tobey, R. E.: Paraplegia, succinylcholine and cardiac arrest. Anesthesiology 32: 359–364, 1970.Google Scholar
  125. 125.
    Tobey, R. E., Jacobsen, P. M., Kahle, C. T., Clubb, R. J., Dean, M. A.: The serum potassium response to muscle relaxants in neural injury. Anesthesiology 37: 332–337, 1972.Google Scholar
  126. 126.
    Tolmie, J. D., Joyce, T. H., Mitchell, G. D.: Succinylcholine danger in the burned patient. Anesthesiology 28: 467–470, 1967.Google Scholar
  127. 127.
    Traber, D. L., Wilson, R. D.: Involvement of the sympathetic nervous system in the pressor response to ketamine. Anesth. Analg. 48: 248–252, 1969.Google Scholar
  128. 128.
    Traber, D. L., Wilson, R. D., Priano, L. L.: Blockade of the hypertensive response to ketamine. Anesth. Analg. 49: 420–426, 1970.Google Scholar
  129. 129.
    Traber, D. L., Wilson, R. D., Priano, L. L.: The effect of alpha-adrenergic blockade on the cardiopulmonary response to ketamine. Anesth. Analg. 50: 737–742, 1971.Google Scholar
  130. 130.
    Virtue, R. W., Lund, L. O., Phelps, M., Vogel, J. H. K., Beckwitt, H., Heron, M.: Difluoromethyl 1, 1, 2 — trifluoro — 2 — chloroethyl ether as an anaesthetic agent: results with dogs, and a preliminary note on observations with man. Canad. Anaesth. Soc. J. 13: 233–241, 1966.Google Scholar
  131. 131.
    Vitcha, J. F.: A history of forane. Anesthesiology 35: 4–7, 1971.Google Scholar
  132. 132.
    Walts, L. F.: Anesthesia of the larynx in the patient with a full stomach. JAMA 192: 705–706, 1965.Google Scholar
  133. 133.
    Waters, D. J., Mapleson, W. W.: Suxamethonium pains: hypothesis and observation. Anaesthesia 26: 127–141, 1971.Google Scholar
  134. 134.
    Weintraub, H. D., Heisterkamp, D.V., Cooperman, L. H.: Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Brit. J. Anaesth. 41: 1048–1052, 1969.Google Scholar
  135. 135.
    Westgate, H. D., Van Bergen, F. H.: Changes in histamine blood levels following d-tubocurarine administration. Canad.Google Scholar
  136. 136.
    Whitwam, J. G., Russell, W. J.: The acute cardiovascular changes and adrenergic blockade by droperidol in man. Brit. J. Anaesth. 43: 581–591, 1971.Google Scholar
  137. 137.
    Wyant, G. M.: Editorial: new concepts in anaesthesia. Canad. Anaesth. Soc. J. 18: 1–2, 1971.Google Scholar
  138. 138.
    Wykoff, C. C.: Aspiration during induction of anesthesia: its prevention. Anesth. Analg. 38: 5–13, 1959.Google Scholar
  139. 139.
    Zauder, H. L., Del Guercio, L. R. M., Feins, N., Barton, N. Wollman, S.: Hemodynamics during neuroleptanalgesia. Anesthesiology 26: 266, 1965.Google Scholar

Copyright information

© Plenum Publishing Corporation 1975

Authors and Affiliations

  • John R. Gordon
    • 1
  1. 1.University of MinnesotaUSA

Personalised recommendations